France· FR:64112581
ILLUCCIX 25 microgrammes, trousse pour préparation radiopharmaceutique
A medicinal product containing trifluoroacétate de gozétotide, registered in France by TELIX INNOVATIONS (BELGIQUE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TRIFLUOROACÉTATE DE GOZÉTOTIDE
- Manufacturer
- TELIX INNOVATIONS (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009551080921 flacon en verre de 25 microgrammes de poudre + 1 flacon en verre de 2,5 mL de solvant + 1 flacon vide.Trousse pour une utilisation avec le générateur Eckert & Ziegler GalliaPharm germanium-68/gallium-68 (68Ge/68Ga)
- cip1334009551081081 flacon en verre de 25 microgrammes de poudre + 1 flacon en verre de 6,4 mL de solvant + 1 flacon vide.Trousse pour une utilisation avec le générateur RE ELiT Galli Ad germanium-68/gallium-68 (68Ge/68Ga)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trifluoroacétate de gozétotide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaILLUCCIXTelix Innovations, Herstal
- FinlandIlluccixTelix Innovations
- SwedenIlluccix 25 mikrogram Beredningssats för radioaktivt läkemedelTelix Innovations
- NetherlandsIlluccix 25 microgram kit voor radiofarmaceutisch preparaatTelix Innovations S.A.
- BelgiumIlluccix 25 µgTelix Innovations
- United StatesLOCAMETZAdvanced Accelerator Applications USA, Inc
- GermanyIlluccixTelix Innovations
- United KingdomIlluccix 25microgram kit for radiopharmaceutical preparationXiel Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Illuccix, Isoprotrace
- Belgium · Illuccix, Isoprotrace
- Cyprus · Illuccix, Isoprotrace
- Czechia · Illuccix, Isoprotrace
- Germany · Illuccix, Isoprotrace
- Denmark · Illuccix, Isoprotrace
- Spain · Illuccix, Isoprotrace
- Finland · Illuccix, Isoprotrace
- United Kingdom (Northern Ireland) · Illuccix, Isoprotrace
- Greece · Illuccix, Isoprotrace
- Ireland · Illuccix
- Iceland · Locametz
- Italy · Illuccix, Viewprost
- Liechtenstein · Locametz
- Luxembourg · Illuccix, Isoprotrace
- Malta · Illuccix, Isoprotrace
- Netherlands · Illuccix, Isoprotrace
- Norway · Illuccix, Isoprotrace
- Poland · Psmatrace
- Portugal · Illuccix, Isoprotrace
- Sweden · Illuccix, Isoprotrace
- Slovakia · Illuccix, Isoprotrace
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9d87c29-3533-4f9c-8e83-db5ffb78c75f GET /v1/drugs/b9d87c29-3533-4f9c-8e83-db5ffb78c75f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64112581",
"date_amm": "2025-04-24",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "TRIFLUOROACÉTATE DE GOZÉTOTIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "trousse pour préparation radiopharmaceutique et trousse pour préparation radiopharmaceutique",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about trifluoroacétate de gozétotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.